Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1955 1
1958 1
1962 1
1963 1
1964 1
1965 1
1973 2
1974 1
1975 1
1977 2
1978 3
1979 4
1980 3
1981 3
1982 5
1983 7
1984 4
1985 4
1986 6
1987 13
1988 13
1989 14
1990 12
1991 15
1992 19
1993 25
1994 24
1995 26
1996 30
1997 34
1998 29
1999 53
2000 42
2001 48
2002 61
2003 80
2004 111
2005 128
2006 131
2007 136
2008 183
2009 176
2010 238
2011 285
2012 390
2013 400
2014 490
2015 532
2016 602
2017 636
2018 763
2019 826
2020 1027
2021 1144
2022 1308
2023 1390
2024 314

Text availability

Article attribute

Article type

Publication date

Search Results

10,562 results

Results by year

Filters applied: . Clear all
Page 1
Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth.
Wimmers F, Burrell AR, Feng Y, Zheng H, Arunachalam PS, Hu M, Spranger S, Nyhoff LE, Joshi D, Trisal M, Awasthi M, Bellusci L, Ashraf U, Kowli S, Konvinse KC, Yang E, Blanco M, Pellegrini K, Tharp G, Hagan T, Chinthrajah RS, Nguyen TT, Grifoni A, Sette A, Nadeau KC, Haslam DB, Bosinger SE, Wrammert J, Maecker HT, Utz PJ, Wang TT, Khurana S, Khatri P, Staat MA, Pulendran B. Wimmers F, et al. Among authors: hu m. Cell. 2023 Oct 12;186(21):4632-4651.e23. doi: 10.1016/j.cell.2023.08.044. Epub 2023 Sep 29. Cell. 2023. PMID: 37776858
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. Among authors: hu mi. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
CDC73-Related Disorders.
Skefos CM, Waguespack SG, Perrier ND, Hu MI. Skefos CM, et al. Among authors: hu mi. 2008 Dec 31 [updated 2023 Sep 21]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. 2008 Dec 31 [updated 2023 Sep 21]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. PMID: 20301744 Free Books & Documents. Review.
Venetoclax in adult acute myeloid leukemia.
Hu M, Li W, Zhang Y, Liang C, Tan J, Wang Y. Hu M, et al. Biomed Pharmacother. 2023 Dec;168:115820. doi: 10.1016/j.biopha.2023.115820. Epub 2023 Nov 6. Biomed Pharmacother. 2023. PMID: 37925935 Free article. Review.
Nanoparticles and Antiviral Vaccines.
Liu S, Hu M, Liu X, Liu X, Chen T, Zhu Y, Liang T, Xiao S, Li P, Ma X. Liu S, et al. Among authors: hu m. Vaccines (Basel). 2023 Dec 27;12(1):30. doi: 10.3390/vaccines12010030. Vaccines (Basel). 2023. PMID: 38250843 Free PMC article. Review.
Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial.
Zhang W, Tong S, Hu B, Wan T, Tang H, Zhao F, Jiao T, Li J, Zhang Z, Cai J, Ye H, Wang Z, Chen S, Wang Y, Li X, Wang F, Cao J, Tian L, Zhao X, Chen M, Wang H, Cai S, Hu M, Bai Y, Lu S. Zhang W, et al. Among authors: hu m. J Immunother Cancer. 2023 Sep;11(9):e007366. doi: 10.1136/jitc-2023-007366. J Immunother Cancer. 2023. PMID: 37730273 Free PMC article. Clinical Trial.
Editorial: Incretin agonists in the treatment of obesity.
Sun X, Hu MG, Li L. Sun X, et al. Among authors: hu mg. Front Endocrinol (Lausanne). 2023 Aug 9;14:1265826. doi: 10.3389/fendo.2023.1265826. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37621651 Free PMC article. No abstract available.
10,562 results
You have reached the last available page of results. Please see the User Guide for more information.